|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||||||
| Deferred offering costs | ||||||||||||
| Cash | ||||||||||||
| Prepaid expenses | ||||||||||||
| Total Current Assets | ||||||||||||
| Cash held in Trust Account | ||||||||||||
| TOTAL ASSETS | ||||||||||||
| Current liabilities | ||||||||||||
| Promissory note - related party | ||||||||||||
| Accrued expenses | ||||||||||||
| Accrued offering costs | ||||||||||||
| Advances from related party | ||||||||||||
| Due to related party | ||||||||||||
| Promissory Notes- related party | ||||||||||||
| Total Current Liabilities | ||||||||||||
| Warrant liabilities | ||||||||||||
| Deferred underwriting fee payable | ||||||||||||
| TOTAL LIABILITIES | ||||||||||||
| Class A ordinary shares, $0.0001 par value; 200,000,000 authorized, 15,093,034 shares at approximately $10.26 and $10.09 redemption value at June 30, 2023 and December 31, 2022, respectively | ||||||||||||
| SHAREHOLDERS’ DEFICIT | ||||||||||||
| Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 7,864,377 and 13,819,711 shares issued and outstanding (excluding 51,634,974 and 45,679,640 shares subject to possible redemption) at June 30, 2021 and December 31, 2020 | ||||||||||||
| Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 14,874,838 shares issued and outstanding at June 30, 2023 and December 31, 2022 | ||||||||||||
| Class A ordinary shares | ||||||||||||
| Class B ordinary shares | ||||||||||||
| Total class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 14,874,838 shares issued and outstanding at June 30, 2023 and December 31, 2022 | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated deficit | ||||||||||||
| SHAREHOLDERS’ DEFICIT | ||||||||||||
| Class A ordinary shares | ||||||||||||
| Class B ordinary shares | ||||||||||||
| TOTAL SHAREHOLDERS’ DEFICIT | ||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT |
Loading...
